{"brief_title": "A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)", "brief_summary": "Study GIPF-002 is a phase 2 study designed to characterize the biologic and clinical effects of IFN-g 1b. The objective of the Study is to characterize the biologic and clinical effects of IFN-g 1b administered to patients with idiopathic pulmonary fibrosis (IPF). The Study will be conducted at multiple sites and enroll 30 patients with IPF who have failed treatment with corticosteroids.", "condition": ["Idiopathic Pulmonary Fibrosis"], "intervention_type": ["Drug"], "intervention_name": ["Interferon-gamma 1b"], "description": ["200 mcg, SQ, 3x per week"], "criteria": "Male or Female 20-79 years old", "gender": "All", "minimum_age": "20 Years", "maximum_age": "79 Years", "healthy_volunteers": "No", "mesh_term": ["Fibrosis", "Pulmonary Fibrosis", "Idiopathic Pulmonary Fibrosis", "Idiopathic Interstitial Pneumonias", "Interferons", "Interferon-gamma"], "id": "NCT00047658"}